Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
May 26, 2022
Yesterday at the annual World Health Assembly in Geneva, member states passed a resolution tabled by the Argentina, Peru, and the UK that aims to strengthen clinical trials to improve public health. As COVID-19 has made abundantly clear, the evidence generated by high-quality clinical trials is esse...
Blog Post
May 09, 2022
Since the start of the 20th century, global average life expectancy has risen from 32 to 72 years. The introduction of antimicrobials—such as antibiotics—to treat infections, combined with vaccines and improved infection control, helped significantly reduce the risks from infectious diseases, which ...
Blog Post
April 28, 2022
In the past two years, we have all learned that the end of a COVID-19 wave is the end of a chapter, not the end of the story. Ongoing COVID transmission means the risk of new variants of pandemic potential is ever present and vaccination remains our best defence. The primary near-term challenges for...
Blog Post
December 20, 2021
High-income countries play a key role in the global response to Omicron. Their decisions can help increase global vaccination coverage, curb the spread of current variants, and prevent the emergence of new ones. Here we outline three actions high-income countries should take to help end the pandemic...
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...